Institutional Review Board, Hospital for Special Surgery
May 24, 2012
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
50 patients. Minimum 10 year follow-up.
Age 18-80 years, Crowe II and II dysplasia of the Hip, THA with a high hip center
Revision THA for dysplasia, Crowe I and IV dysplasia
Chitranjan S. Ranawat MD